HAMILTON, Ontario, March 12, 2019 / – Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company that develops innovative mobile health (mHealth) and telemedicine solutions for the community-based healthcare market, today announced that Mr. Rob Prouse has joined the Management Team as Reliq’s Chief Technology Officer.
“We are thrilled to welcome Rob Prouse to the Reliq team as CTO,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies. “Rob has over 22 years of software development experience and has produced enterprise class software for the North American, European and Asian markets. Rob has built software that is used by some of the world’s largest companies and that serves millions of users. He is an expert in the Microsoft .NET stack and is recognized by Microsoft as a Microsoft MVP (Most Valuable Professional) for his contributions and thought leadership in the software community. Rob’s diverse experience and impressive track record in designing, developing and delivering enterprise grade software on-time and on-budget will be invaluable to Reliq as we continue to grow our business.” Rob leads the open source NUnit development team and has contributed to many open source projects. NUnit is the most popular unit testing framework for .NET with over 34 million downloads on NuGet alone. Rob is passionate about agile engineering and methodologies.
The Company also announced that Dr. Bassma Ghali has moved into the Chief Innovation Officer role. In this position Reliq will be able to leverage Dr. Ghali’s expertise and experience in Artificial Intelligence and Machine Learning to develop novel algorithms and predictive analytics for the iUGO platform. “We are very excited to have Dr. Ghali drive Reliq’s next generation technology innovations, creating novel intellectual property and introducing new capabilities into our platform focused on prevention and not just detection. Her efforts will allow Reliq to bring powerful new functionality to our platform to further differentiate ourselves in the market.” Dr. Ghali is a serial entrepreneur with expertise in wearable medical device technology, software development, telemonitoring, machine learning (AI), data collection and analysis. She holds a PhD in Biomedical Engineering from the University of Toronto, where she conducted her research in the PRISM (Paediatric Rehabilitation Intelligent Systems Multidisciplinary) Lab at the Holland Bloorview Kids Rehabilitation Hospital, the largest paediatric rehabilitation hospital in Canada.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
ABOUT RELIQ HEALTH
Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.
For further information please contact:
Investor Relations at ir@reliqhealth.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.
We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the “Company“) does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
